Untuk mengetahui efektivitas, penerimaan dan keamanan Implanon@, dil.akuknn uji klinik acak multisenter NorplnnP dipakni sebagai pembanding. Sebanyak 898 wanita direkrut dalnm penelitian ini di delnpan senter "Follow-up" dilakuknn selama 3 tahun. Waku insersi rata- 898 women were recruited into an eight centre, randomized clinical trinl. One subject was excludedfrom the study because she had been already pregnant when the implant inserted. Follow up scheduled fqr 3 years. The mean insertion time was 0.8 minute for Implanon@ and 4.4 minutes for NorplanP. The mean removal time was 4.9 minutes for Implanon@ and 30.2 minutes for Norplan9. These dffirences are statiscally significant (p<0.01). In three-year follow up, the study showed none of the subjects became pregnant in both groups. One-year continuation rates were 97.j per hundred women for Implannn@ and 97.6 per hunàred women for Norplnn9. After three years the continuntion rates were 90.6 anrl 92.0 respectively. ln Implnnon@ group thcre were 42 subjects discontinued the method use. The reasons were: bleeding irregularities (4 subject), arnenorrhoea (1 subject), other medical reasons (4 subjects) non-medical reosons (24 subjects) and lost to follow-up (9 subjects).
The assessments of the condition of the implant site are summarizedin Table 7 . Almost all of the subjects reported no abnormalities during any of the assessments. In Table 7 group swelling was reported by three subjects of whom one subject had also reported redness. One subject discontinued due to reaction at implant site (infection). In the Norplant@ group three subjects reported pain and one subject swelling. An additional subject in the Norplant@ group reported expulsion on day 110 and discontinued from the study.
A complication during implantation (Table 8) There was a slight mean weight gain over the year of study (1.15 kg), however there was no subject discontinued the method use for this reason. With regard to blood pressure, there was a small mean decrease both in systolic and diastolic blood pressure, in both groups, over the period of three year. There was no subject discontinued the method use for this particular reason. Overall, neither implant gave rise to the unexpected side effects.
Similarly, no non medical reasons could be related to either implant group although as stated below, non medical reasons are sometimes given by subjects who wish to discontinue the method even though they may not be the real reasons for discontinuation. Hence, caution must be applied in interpretation of discontinuation for non medical reasons. It should be stressed that this is an analysis ofreasons for discontinuation as given by the subject and interpreted by the clinic physician to be recorded on data collection form. Hence it relates to the perceptions of the woman about the method. The reason for discontinuation, howeveç can be unrelated to any physiological or perceived event but could be a reason which the subject felt would be considered appropriate by the investigator.
